GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Nanjing Hicin Pharmaceutical Co Ltd (SZSE:300584) » Definitions » Change In Inventory

Nanjing Hicin Pharmaceutical Co (SZSE:300584) Change In Inventory : ¥0.0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2017. Start your Free Trial

What is Nanjing Hicin Pharmaceutical Co Change In Inventory?

Nanjing Hicin Pharmaceutical Co's change in inventory for the quarter that ended in Mar. 2025 was ¥0.0 Mil. It means Nanjing Hicin Pharmaceutical Co's inventory stayed the same from Dec. 2024 to Mar. 2025 .

Nanjing Hicin Pharmaceutical Co's change in inventory for the fiscal year that ended in Dec. 2024 was ¥-13.4 Mil. It means Nanjing Hicin Pharmaceutical Co's inventory increased by ¥13.4 Mil from Dec. 2023 to Dec. 2024 .

Nanjing Hicin Pharmaceutical Co's Total Inventories for the quarter that ended in Mar. 2025 was ¥86.6 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Nanjing Hicin Pharmaceutical Co's Days Inventory for the quarter that ended in Mar. 2025 was 396.13.

Inventory Turnover measures how fast the company turns over its inventory within a year. Nanjing Hicin Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2025 was 0.23.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Nanjing Hicin Pharmaceutical Co's Inventory-to-Revenue for the quarter that ended in Mar. 2025 was 0.60.


Nanjing Hicin Pharmaceutical Co Change In Inventory Historical Data

The historical data trend for Nanjing Hicin Pharmaceutical Co's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanjing Hicin Pharmaceutical Co Change In Inventory Chart

Nanjing Hicin Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.10 17.48 -9.37 -22.01 -13.44

Nanjing Hicin Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Nanjing Hicin Pharmaceutical Co Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Hicin Pharmaceutical Co  (SZSE:300584) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Nanjing Hicin Pharmaceutical Co's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=86.137/19.842*365 / 4
=396.13

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Nanjing Hicin Pharmaceutical Co's Inventory Turnover for the quarter that ended in Mar. 2025 is calculated as

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Nanjing Hicin Pharmaceutical Co's Inventory to Revenue for the quarter that ended in Mar. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nanjing Hicin Pharmaceutical Co Change In Inventory Related Terms

Thank you for viewing the detailed overview of Nanjing Hicin Pharmaceutical Co's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanjing Hicin Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
Heng Road 1, Nanjing Economic and Technological Development Zone, Jiangsu Province, Nanjing, CHN, 210009
Nanjing Hicin Pharmaceutical Co Ltd is a China-based company engaged in producing pharmaceutical preparations. In addition, it is also involved in manufacturing synthetic chemicals, conducting new drug research and development as well as technical transferring. The company produces series of the medicines such as antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for the cardio-cerebral system and immuno-modulate agents. The active pharmaceutical ingredients, omeprazole sodium for injection, cefepime hydrochloride for Injection and lansoprazole tablets are exported by the firm into South-Asian countries, South-American countries and European countries.
Executives
Cao Yu Ping Directors, executives
Yan Mei Qiang Directors, executives
Jiang Xiang Ming Executives
Gu Hai Independent director

Nanjing Hicin Pharmaceutical Co Headlines

No Headlines